A Study to Investigate the Safety, Tolerability, Drug Levels and Drug Effects of BMS-986326 in Adult Participants With Different Forms of Lupus

NCT06013995 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

Lupus

Interventions

DRUG: BMS-986326
OTHER: Placebo for BMS-986326

Sponsor

Bristol-Myers Squibb